RTOG 0247: A Randomized Phase II Study of Neoadjuvant Capecitabine and Irinotecan or Capecitabine and Oxaliplatin with Concurrent Radiation Therapy for Patients with Locally Advanced Rectal Cancer

類似資料

• Efficacy Endpoints of RTOG 0247: A Randomized Phase II Study of Neoadjuvant Radiation Therapy Plus Concurrent Capecitabine and Irinotecan or Capecitabine and Oxaliplatin for Patients with Locally Advanced Rectal Cancer
  著者:: Wong, Stuart J., 等
  出版事項: (2014)
• Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabine
  著者:: Krishnamurthi, Smitha S., 等
  出版事項: (2008)
• UGT1A1 Genotype-guided Phase I Study of Irinotecan, Oxaliplatin, and Capecitabine
  著者:: Goetz, Matthew P., 等
  出版事項: (2013)
• Response of Capecitabine and Oxaliplatin Chemotherapy in Metastatic Colorectal Carcinoma
  著者:: Asma Abdul Rashid, 等
  出版事項: (2025-01-01)
• Prolonged Neutropenia After Neoadjuvant Radiation Therapy and Chemotherapy Using Oxaliplatin and Capecitabine for Rectal Cancer
  著者:: McFarland, Daniel C., 等
  出版事項: (2011)